About R1 Therapeutics
R1 Therapeutics is a clinical-stage biopharmaceutical company that develops first-in-class treatments for kidney disease patients.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
London, United Kingdom
Year Founded
2024
Team Size
1-10
Tracked Since
Oct 4, 2026
Web & Domain Identity
Official Website
r1therapeutics.com
Domain Registered Date
Sep 22, 2025
Social & Network Presence
X / Twitter Profile
@companies
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $80,500,000 · Series-A
Backed by Samsara Biocapital
- Capital Raise
Raised $77,500,000 · Series-A
Backed by Abingworth, DaVita Venture Group
- Milestone
Website domain registered
r1therapeutics.com
- Milestone
Company founded
London, United Kingdom
Investors & Backers
Abingworth
Curie.Bio
DaVita Venture Group
F-Prime Capital
Samsara Biocapital
SymBiosis
U.S. Renal Care
Funding History
Series-A equity
· Sep 30, 2026
Round backers: Samsara Biocapital
$80,500,000 clinicaltrialsarena.com
Series-A equity
· Mar 17, 2026
Round backers: Abingworth, DaVita Venture Group, F-Prime Capital, Curie.Bio, SymBiosis, U.S. Renal Care
$77,500,000 pharmiweb.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026